Cargando…

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study

OBJECTIVE: We aim to compare the cost‐effectiveness of the old cytology programme with the new high‐risk human papillomavirus (hrHPV) screening programme, using performance indicators from the new Dutch hrHPV screening programme. DESIGN: Model‐based cost‐effectiveness analysis. SETTING: The Netherla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, EEL, Naber, SK, Aitken, CA, de Koning, HJ, van Ballegooijen, M, de Kok, IMCM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818441/ https://www.ncbi.nlm.nih.gov/pubmed/32638462 http://dx.doi.org/10.1111/1471-0528.16400

Ejemplares similares

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study
por: Kaljouw, Sylvia, et al.
Publicado: (2022)

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
por: van Ballegooijen, M., et al.
Publicado: (1997)

Effects of cancer screening restart strategies after COVID-19 disruption
por: Kregting, L., et al.
Publicado: (2020)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment
por: Hofman, Robine, et al.
Publicado: (2014)

The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study
por: Naber, Steffie K., et al.
Publicado: (2016)

Low risk of cervical cancer during a long period after negative screening in the Netherlands
por: van den Akker-van Marle, M E, et al.
Publicado: (2003)

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua
por: Campos, Nicole G, et al.
Publicado: (2017)

Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria
por: Modibbo, Fatima, et al.
Publicado: (2017)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
por: Ibáñez, R., et al.
Publicado: (2021)

Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management
por: Desai, Kanan T., et al.
Publicado: (2022)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

PAR for transferability of HPV interventions among underserved communities in the Netherlands
por: De Zeeuw, J, et al.
Publicado: (2023)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy
por: Aitken, Clare A., et al.
Publicado: (2019)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

HPV-based cervical cancer screening in Nicaragua: from testing to treatment
por: Holme, Francesca, et al.
Publicado: (2020)

Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening
por: Duijm, L E M, et al.
Publicado: (2004)

Effectiveness and costs of an implemented primary HPV cervical screening programme in Sweden – A population based cohort study
por: Bergengren, Lovisa, et al.
Publicado: (2021)

Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study
por: Aitken, Clare A., et al.
Publicado: (2019)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology
por: de Kok, Inge M. C. M., et al.
Publicado: (2020)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study
por: Jansen, Erik E. L., et al.
Publicado: (2022)

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
por: Chrysostomou, Andreas C., et al.
Publicado: (2018)

False positive cervical HPV screening test results
por: Schiffman, Mark, et al.
Publicado: (2019)

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
por: Simms, Kate T., et al.
Publicado: (2017)

Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced
por: Beddoe, Ann Marie
Publicado: (2021)

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
por: Fogelberg, Sara, et al.
Publicado: (2020)

Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
por: Figueiredo, Daniel, et al.
Publicado: (2023)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
por: Matthijsse, Suzette M., et al.
Publicado: (2018)

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
por: Cuzick, J, et al.
Publicado: (2000)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Health System Barriers for HPV-vaccine uptake in females with a Turkish or Moroccan Migration background in the Netherlands
por: De Zeeuw, J, et al.
Publicado: (2022)

Cost-effectiveness of Screening Program for Chronic Q Fever, the Netherlands
por: de Boer, Pieter T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tpgspkmim2c2c3uhrtcm5takke